LLY
755.22
+3.01%↑
JNJ
153.86
-0.07%↓
UNH
378.43
-0.51%↓
ABBV
189.92
+3.08%↑
ABT
131.96
-0.98%↓
LLY
755.22
+3.01%↑
JNJ
153.86
-0.07%↓
UNH
378.43
-0.51%↓
ABBV
189.92
+3.08%↑
ABT
131.96
-0.98%↓
LLY
755.22
+3.01%↑
JNJ
153.86
-0.07%↓
UNH
378.43
-0.51%↓
ABBV
189.92
+3.08%↑
ABT
131.96
-0.98%↓
LLY
755.22
+3.01%↑
JNJ
153.86
-0.07%↓
UNH
378.43
-0.51%↓
ABBV
189.92
+3.08%↑
ABT
131.96
-0.98%↓
LLY
755.22
+3.01%↑
JNJ
153.86
-0.07%↓
UNH
378.43
-0.51%↓
ABBV
189.92
+3.08%↑
ABT
131.96
-0.98%↓
24h
Actual
Mínimo
1.61
Máximo
1.68
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +846.75% upside |
Próximas Ganancias | 11 ago 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 16 USD 846.75%
Máximo 16 USD
Mínimo 16 USD
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
1 ratings
1
Comprar
0
Mantener
0
Vender
De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$